April 12, 2010 − James F. Young, Ph.D., has been elected to the Board of Directors of Novavax, Inc. He previously served as president of research and development at MedImmune. Prior to that, Dr. Young was influential in building the department of molecular genetics at Smith Kline & French Laboratories (now part of GlaxoSmithKline) and culminated as director, department of molecular genetics. Before that time, Dr. Young was on the faculty of the department of microbiology at Mount Sinai School of Medicine in New York, NY. Novavax, Inc. is a Rockville-based clinical-stage biotechnology company creating vaccines to address a broad range of infectious diseases worldwide, including H1N1, using proprietary virus-like-particle (VLP) technology.
| Visionary: The Odyssey of Sir Arthur C. Clarke April 2, 2012 - Visionary offers the first full-life chronicle of the man whose fiction, including his groundbreaking collaboration with Stanley Kubrick on the film "2001," has received all of science fiction’s highest awards, and whose visionary contribution to science has earned him the nickname, "Godfather of the Communication Satellite." Read more at The British Interplanetary Society... |
 |
 |
 |
|
||
 |
|
 |
|
||
|
|
| DBED's Cybersecurity Blog |
| Corridor Inc.’s Strategic Partners |
| CENTER MARYLAND |
| PRESSBOX |
| GREATER BALTIMORE COMMITTEE |
